Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > SBM mgmt, get on with it

<< Previous

Bullboard Posts

Next >>

Comment by navajojoeon Jun 02, 2023 8:29am

161 Views

Post# 35476490

RE:RE:SBM mgmt, get on with it

Considering we gave Abbvie a GLOBAL and EXCLUSIVE licence for TFC-1067, and not JUST for TFC-1067 but some related products that come from certain patents, we darn well better get something significant in the form of CASH.

If this turns out to be another R&F joke, the next annual meeting won't be pleasant for management.

And we are coming up on the 1-year anniversary of the Abbvie signing, and so far have seen diddly squat.

<< Previous

Bullboard Posts

Next >>

Is China getting serious? Rheinmetall and Almonty Industries profit